Sabine Harig

726 total citations
12 papers, 548 citations indexed

About

Sabine Harig is a scholar working on Oncology, Immunology and Epidemiology. According to data from OpenAlex, Sabine Harig has authored 12 papers receiving a total of 548 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Immunology and 3 papers in Epidemiology. Recurrent topics in Sabine Harig's work include Pancreatic and Hepatic Oncology Research (7 papers), Neuroendocrine Tumor Research Advances (3 papers) and Immunotherapy and Immune Responses (3 papers). Sabine Harig is often cited by papers focused on Pancreatic and Hepatic Oncology Research (7 papers), Neuroendocrine Tumor Research Advances (3 papers) and Immunotherapy and Immune Responses (3 papers). Sabine Harig collaborates with scholars based in Germany, United States and Netherlands. Sabine Harig's co-authors include John G. Gribben, Mathias Witzens‐Harig, Angela M. Krackhardt, Dirk Jäger, Andreas Trojan, Ryan Broderick, Jan Schmidt, F. Stephen Hodi, Ulrich Abel and Markus W. Büchler and has published in prestigious journals such as Journal of Clinical Oncology, Blood and International Journal of Molecular Sciences.

In The Last Decade

Sabine Harig

12 papers receiving 543 citations

Peers

Sabine Harig

ONCOL

IMMUN

GENET

Cansu Cimen Bozkus United States

Benedetta Urbini Italy

Jeffrey J. Pu United States

Justus Duyster Germany

Andreas Draube Germany

Andreas Himmelmann Switzerland

Myriam Foglietta Italy

D. Huhn Germany

Yunfei Shi China

Jettie J.F. Muris Netherlands

Cansu Cimen Bozkus United States

Sabine Harig

236 ×0.9

ONCOL

297 ×1.1

IMMUN

88 ×0.6

GENET

147 ×1.1

82 ×1.2

Citations per year, relative to Sabine Harig Sabine Harig (= 1×) peers Cansu Cimen Bozkus

Countries citing papers authored by Sabine Harig

Since Specialization

Citations

This map shows the geographic impact of Sabine Harig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sabine Harig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sabine Harig more than expected).

Fields of papers citing papers by Sabine Harig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sabine Harig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sabine Harig. The network helps show where Sabine Harig may publish in the future.

Co-authorship network of co-authors of Sabine Harig

This figure shows the co-authorship network connecting the top 25 collaborators of Sabine Harig. A scholar is included among the top collaborators of Sabine Harig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sabine Harig. Sabine Harig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Karakhanova, Svetlana, Eduard Ryschich, Sabine Harig, et al.. (2015). Prognostic and predictive value of immunological parameters for chemoradioimmunotherapy in patients with pancreatic adenocarcinoma. British Journal of Cancer. 112(6). 1027–1036. 42 indexed citations

Berger, Anne, et al.. (2014). Chemotherapy for advanced pancreatic adenocarcinoma in elderly patients (≥70 years of age): A retrospective cohort study at the National Center for Tumor Diseases Heidelberg. Pancreatology. 14(3). 211–215. 19 indexed citations

Karakhanova, Svetlana, Sabine Harig, Jan Schmidt, et al.. (2014). Influence of Interferon-Alpha Combined with Chemo (Radio) Therapy on Immunological Parameters in Pancreatic Adenocarcinoma. International Journal of Molecular Sciences. 15(3). 4104–4125. 14 indexed citations

Schmidt, Jan, Ulrich Abel, Jürgen Debus, et al.. (2012). Open-Label, Multicenter, Randomized Phase III Trial of Adjuvant Chemoradiation Plus Interferon Alfa-2b Versus Fluorouracil and Folinic Acid for Patients With Resected Pancreatic Adenocarcinoma. Journal of Clinical Oncology. 30(33). 4077–4083. 111 indexed citations

Märten, Angela, Jürgen Debus, Sabine Harig, et al.. (2010). CapRI: Final results of the open-label, multicenter, randomized phase III trial of adjuvant chemoradiation plus interferon-α2b (CRI) versus 5-FU alone for patients with resected pancreatic adenocarcinoma (PAC).. Journal of Clinical Oncology. 28(18_suppl). LBA4012–LBA4012. 7 indexed citations

Märten, Angela, Moritz N. Wente, Jennifer Ose, et al.. (2009). An open label randomized multicentre phase IIIb trial comparing parenteral substitution versus best supportive nutritional care in subjects with pancreatic adenocarcinoma receiving 5-FU plus oxaliplatin as 2ndor higher line chemotherapy regarding clinical benefit - PANUSCO. BMC Cancer. 9(1). 412–412. 4 indexed citations

Märten, Angela, Jan Schmidt, Jennifer Ose, et al.. (2009). A Randomized Multicentre Phase II Trial Comparing Adjuvant Therapy in Patients with Interferon Alpha-2b and 5-FU Alone or in Combination with Either External Radiation Treatment and Cisplatin (CapRI) or Radiation alone regarding Event-Free Survival – CapRI-2. BMC Cancer. 9(1). 160–160. 21 indexed citations

Krackhardt, Angela M., et al.. (2002). Identification of tumor-associated antigens in chronic lymphocytic leukemia by SEREX. Blood. 100(6). 2123–2131. 105 indexed citations

Krackhardt, Angela M., et al.. (2002). T-cell responses against chronic lymphocytic leukemia cells: implications for immunotherapy. Blood. 100(1). 167–173. 68 indexed citations

10.

Harig, Sabine, Mathias Witzens‐Harig, Angela M. Krackhardt, et al.. (2001). Induction of cytotoxic T-cell responses against immunoglobulin V region–derived peptides modified at human leukocyte antigen–A2 binding residues. Blood. 98(10). 2999–3005. 47 indexed citations

11.

Trojan, Andreas, Mathias Witzens‐Harig, Joachim L. Schultze, et al.. (2001). Generation of cytotoxic T lymphocytes against native and altered peptides of human leukocyte antigen-A*0201 restricted epitopes from the human epithelial cell adhesion molecule.. PubMed. 61(12). 4761–5. 41 indexed citations

12.

Ladetto, Marco, John W. Donovan, Sabine Harig, et al.. (2000). Real-time polymerase chain reaction of immunoglobulin rearrangements for quantitative evaluation of minimal residual disease in multiple myeloma. Biology of Blood and Marrow Transplantation. 6(3). 241–253. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact